Ingelheim am Rhein, Germany

KoHerbert

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Kg. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: KoHerbert. Retrieved from https://idiyas.com/inventor/koherbert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: KoHerbert: Innovator in Antihypertensive Agents

Introduction

KoHerbert is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive agents. His work has led to the creation of innovative compounds that have the potential to improve health outcomes for patients with hypertension.

Latest Patents

KoHerbert holds a patent for "Aryloxy-aminoalkanes, and antihypertensive use thereof." This patent describes and discloses aryloxy-aminoalkanes that are useful as antihypertensive agents. His innovative approach in this area showcases his commitment to advancing medical science and improving patient care.

Career Highlights

Throughout his career, KoHerbert has been associated with Boehringer Ingelheim KG, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to collaborate with other talented professionals in the field. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

KoHerbert has worked alongside esteemed colleagues such as Franz Esser and Wolfgang Hoefke. These collaborations have fostered an environment of innovation and have contributed to the successful development of new pharmaceutical solutions.

Conclusion

KoHerbert's contributions to the field of antihypertensive agents exemplify the impact of dedicated inventors in the pharmaceutical industry. His innovative work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…